Related references
Note: Only part of the references are listed.Soluble amyloid β-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration
Ming Jin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
High-molecular-weight β-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients
Hiroaki Fukumoto et al.
FASEB JOURNAL (2010)
Amyloid β-Protein Dimers Rapidly Form Stable Synaptotoxic Protofibrils
Brian O'Nuallain et al.
JOURNAL OF NEUROSCIENCE (2010)
Stabilization of neurotoxic Alzheimer amyloid-β oligomers by protein engineering
Anders Sandberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Annular Protofibrils Are a Structurally and Functionally Distinct Type of Amyloid Oligomer
Rakez Kayed et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Isolation and Characterization of Patient-derived, Toxic, High Mass Amyloid β-Protein (Aβ) Assembly from Alzheimer Disease Brains
Akihiko Noguchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
A highly insoluble state of Aβ similar to that of Alzheimer's disease brain is found in Arctic APP transgenic mice
Ola Philipson et al.
NEUROBIOLOGY OF AGING (2009)
An amyloid-β protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer's disease
Anna Lord et al.
NEUROBIOLOGY OF DISEASE (2009)
Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
Ganesh M. Shankar et al.
NATURE MEDICINE (2008)
Aβ oligomer-mediated long-term potentiation impairment involves protein phosphatase 1-dependent mechanisms
Marlen Knobloch et al.
JOURNAL OF NEUROSCIENCE (2007)
Natural oligomers of the Alzheimer amyloid-β protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway
Ganesh M. Shankar et al.
JOURNAL OF NEUROSCIENCE (2007)
Soluble protein oligomers in neurodegeneration:: lessons from the Alzheimer's amyloid β-peptide
Christian Haass et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Aβ oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease
Pascale N. Lacor et al.
JOURNAL OF NEUROSCIENCE (2007)
A beta Oligomers - a decade of discovery
Dominic M. Walsh et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Effects of secreted oligomers of amyloid β-protein on hippocampal synaptic plasticity:: a potent role for trimers
M Townsend et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
A specific amyloid-β protein assembly in the brain impairs memory
S Lesné et al.
NATURE (2006)
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study
O Hansson et al.
LANCET NEUROLOGY (2006)
The Arctic Alzheimer mutation facilitates early intraneuronal A beta aggregation and senile plaque formation in transgenic mice
A Lord et al.
NEUROBIOLOGY OF AGING (2006)
Physicochemical characteristics of soluble oligomeric Aβ and their pathologic role in Alzheimer's disease
D Watson et al.
NEUROLOGICAL RESEARCH (2005)
Small non-fibrillar assemblies of amyloid β-protein bearing the Arctic mutation induce rapid neuritic degeneration
BM Whalen et al.
NEUROBIOLOGY OF DISEASE (2005)
Globular amyloid β-peptide1-42 oligomer -: a homogenous and stable neuropathological protein in Alzheimer's disease
S Barghorn et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Dopamine melanin-loaded PC12 cells:: a model for studies on pigmented neurons
A Östergren et al.
PIGMENT CELL RESEARCH (2005)
Amyloid-β oligomers are inefficiently measured by enzyme-linked immunosorbent assay
C Stenh et al.
ANNALS OF NEUROLOGY (2005)
Amyloid β protein immunotherapy neutralizes Aβ oligomers that disrupt synaptic plasticity in vivo
I Klyubin et al.
NATURE MEDICINE (2005)
Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease
DG Georganopoulou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Average protein density is a molecular-weight-dependent function
H Fischer et al.
PROTEIN SCIENCE (2004)
Soluble Arctic amyloid β protein inhibits hippocampal long-term potentiation in vivo
I Klyubin et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Self-assembly of Aβ1-42 into globular neurotoxins
BA Chromy et al.
BIOCHEMISTRY (2003)
Alzheimer's disease-affected brain:: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss
YS Gong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Truncated beta-amyloid peptide species in pre-clinical Alzheimer's disease as new targets for the vaccination approach
N Sergeant et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Spherical aggregates of β-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3β
M Hoshi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
R Kayed et al.
SCIENCE (2003)
Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo
DM Walsh et al.
NATURE (2002)
Correlation between elevated levels of amyloid β-peptide in the brain and cognitive decline
J Näslund et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Share Paper
